The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
De Novo Mutations in Moderate or Severe Intellectual Disability
Open accessAbstract
Genetics is believed to have an important role in intellectual disability (ID). Recent studies have emphasized the involvement of de novo mutations (DNMs) in ID but the extent to which they contribute to its pathogenesis and the identity of the corresponding genes remain largely unknown. Here, we report a screen for DNMs in subjects with moderate or severe ID. We sequenced the exomes of 41 probands and their parents, and confirmed 81 DNMs affecting the coding sequence or consensus splice sites (1.98 DNMs/proband). We observed a significant excess of de novo single nucleotide substitutions and loss-of-function mutations in these cases compared to control subjects, suggesting that at least a subset of these variations are pathogenic. A total of 12 likely pathogenic DNMs were identified in genes previously associated with ID (ARID1B, CHD2, FOXG1, GABRB3, GATAD2B, GRIN2B, MBD5, MED13L, SETBP1, TBR1, TCF4, WDR45), resulting in a diagnostic yield of ∼29%. We also identified 12 possibly pathogenic DNMs in genes (HNRNPU, WAC, RYR2, SET, EGR1, MYH10, EIF2C1, COL4A3BP, CHMP2A, PPP1CB, VPS4A, PPP2R2B) that have not previously been causally linked to ID. Interestingly, no case was explained by inherited mutations. Protein network analysis indicated that the products of many of these known and candidate genes interact with each other or with products of other ID-associated genes further supporting their involvement in ID. We conclude that DNMs represent a major cause of moderate or severe ID.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in CHD2 have been detected in individuals with a diagnosis of ASD (22), ID (73) or epilepsy (82,83,87,89)”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [73]
In the citing paper
“CHD2 has been associated with ASD (22,23), ID (73), epilepsy (82,87) and photosensitivity (83).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165 · cited 2×
“DNMs in TBR1 have been found in patients with ID and the variable presence of ASD or growth retardation [8,9,21,29,30].”
BackgroundDe novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734
Diagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
De novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514
De Novo Gene Disruptions in Children on the Autistic Spectrum
Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., Yamrom, B., Lee, Y.-H., Narzisi, G., Leotta, A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.04.009 · Cited by 1,446
Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders
O’Roak, B. J., Vives, L., Fu, W., Egertson, J. D., Stanaway, I. B., Phelps, I. G., Carvill, G., Kumar, A., Lee, C., Ankenman, K., et al. (2012) · Science · doi:10.1126/science.1227764 · Cited by 1,240
Genome sequencing identifies major causes of severe intellectual disability
Gilissen, C., Hehir-Kwa, J. Y., Thung, D. T., van de Vorst, M., van Bon, B. W. M., Willemsen, M. H., Kwint, M., Janssen, I. M., Hoischen, A., Schenck, A., et al. (2014) · Nature · doi:10.1038/nature13394 · Cited by 1,125
Rauch, A., Wieczorek, D., Graf, E., Wieland, T., Endele, S., Schwarzmayr, T., Albrecht, B., Bartholdi, D., Beygo, J., Di Donato, N., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61480-9 · Cited by 1,041
Jones, M. W., Errington, M. L., French, P. J., Fine, A., Bliss, T., Garel, S., Charnay, P., Bozon, B., Laroche, S., & Davis, S. (2001) · Nature Neuroscience · doi:10.1038/85138 · Cited by 925
A de novo paradigm for mental retardation.
Vissers, L. E. L. M., de Ligt, J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., van Lier, B., Arts, P., Wieskamp, N., del Rosario, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.712 · Cited by 852
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2646 · Cited by 687
Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA functionPreprint
Isken, O., & Maquat, L. E. (2007) · Genes & Development · doi:10.1101/gad.1566807 · Cited by 609
Endele, S., Rosenberger, G., Geider, K., Popp, B., Tamer, C., Stefanova, I., Milh, M., Kortüm, F., Fritsch, A., Pientka, F. K., et al. (2010) · Nature Genetics · doi:10.1038/ng.677 · Cited by 499
De novo mutations of SETBP1 cause Schinzel-Giedion syndrome
Hoischen, A., van Bon, B. W. M., Gilissen, C., Arts, P., van Lier, B., Steehouwer, M., de Vries, P., de Reuver, R., Wieskamp, N., Mortier, G., et al. (2010) · Nature Genetics · doi:10.1038/ng.581 · Cited by 489
Identification of microcephalin, a protein implicated in determining the size of the human brain
Jackson, A. P., Eastwood, H., Bell, S. M., Adu, J., Toomes, C., Carr, I. M., Roberts, E., Hampshire, D. J., Crow, Y. J., Mighell, A. J., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341283 · Cited by 482
Saitsu, H., Nishimura, T., Muramatsu, K., Kodera, H., Kumada, S., Sugai, K., Kasai-Yoshida, E., Sawaura, N., Nishida, H., Hoshino, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2562 · Cited by 474
De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia
Xu, B., Ionita-Laza, I., Roos, J. L., Boone, B., Woodrick, S., Sun, Y., Levy, S., Gogos, J. A., & Karayiorgou, M. (2012) · Nature Genetics · doi:10.1038/ng.2446 · Cited by 442 · cited 2×
“We found a significant excess of these de novo nonsense and splice site mutations in the probands of our cohort when compared to data from exome sequencing of 54 control trios with no family history of ID [4,11] or of 593 quartets, including unaffected siblings of individuals with ASD (R binomial test, p = 0.”
BackgroundResultClinical application of exome sequencing in undiagnosed genetic conditions
Need, A. C., Shashi, V., Hitomi, Y., Schoch, K., Shianna, K. V., McDonald, M., Meisler, M. H., & Goldstein, D. B. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-100819 · Cited by 438
Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice
Lehnart, S. E., Mongillo, M., Bellinger, A. M., Lindegger, N., Chen, B.-X., HSUEH, W. H., Reiken, S. R., Wronska, A., Drew, L., Ward, C. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35346 · Cited by 413
Genetics of Early Onset Cognitive Impairment
Ropers, H. (2010) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082509-141640 · Cited by 398
GeneMANIA Prediction Server 2013 Update
Zuberi, K., Franz, M., Rodriguez, H., Montojo, J., Lopes, C. T., Bader, G. D., & Morris, Q. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt533 · Cited by 396
Haack, T. B., Hogarth, P., Kruer, M. C., Gregory, A., Wieland, T., Schwarzmayr, T., Graf, E., Sanford, L., Meyer, E., Kara, E., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.10.019 · Cited by 360
Hamdan, F. F., Gauthier, J., Araki, Y., Lin, D.-T., Yoshizawa, Y., Higashi, K., Park, A.-R., Spiegelman, D., Dobrzeniecka, S., Piton, A., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.02.001 · Cited by 349
ESCRT-III recognition by VPS4 ATPases
Stuchell‐Brereton, M. D., Skalicky, J. J., Kieffer, C., Karren, M. A., Ghaffarian, S., & Sundquist, W. I. (2007) · Nature · doi:10.1038/nature06172 · Cited by 334
Zweier, C., Peippo, M. M., Hoyer, J., Sousa, S., Bottani, A., Clayton-Smith, J., Reardon, W., Saraiva, J., Cabral, A., Göhring, I., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/515583 · Cited by 317
Ryanodine Receptors: Structure and Function
Petegem, F. V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.349068 · Cited by 290
Disruption of an EHMT1-Associated Chromatin-Modification Module Causes Intellectual Disability
Kleefstra, T., Kramer, J. M., Neveling, K., Willemsen, M. H., Koemans, T. S., Vissers, L. E. L. M., Wissink-Lindhout, W. M., Fencková, M., van den Akker, W. M. R., Kasri, N. N., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.003 · Cited by 264
Hoyer, J., Ekici, A. B., Endele, S., Popp, B., Zweier, C., Wiesener, A., Wohlleber, E., Dufke, A., Rossier, E., Petsch, C., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.02.007 · Cited by 263
Talkowski, M. E., Mullegama, S. V., Rosenfeld, J. A., van Bon, B. W. M., Shen, Y., Repnikova, E. A., Gastier-Foster, J., Thrush, D. L., Kathiresan, S., Ruderfer, D. M., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.09.011 · Cited by 249
Membrane Fission Reactions of the Mammalian ESCRT Pathway
McCullough, J., Colf, L. A., & Sundquist, W. I. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072909-101058 · Cited by 249
Kortüm, F., Das, S., Flindt, M., Morris-Rosendahl, D. J., Stefanova, I., Goldstein, A. C., Horn, D., Klopocki, E., Kluger, G. J., Martin, P., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.087528 · Cited by 243
Froyen, G., Corbett, M. A., Vandewalle, J., Järvelä, I. E., Lawrence, O., Meldrum, C. J., Bauters, M., Govaerts, K., Vandeleur, L., Esch, H. V., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.11.002 · Cited by 233
Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance
Morita, E., Colf, L. A., Karren, M. A., Sandrin, V., Rodesch, C. K., & Sundquist, W. I. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005938107 · Cited by 217
GRIN2B mutations in west syndrome and intellectual disability with focal epilepsy
Lemke, J. R., Hendrickx, R., Geider, K., Laube, B., Schwake, M., Harvey, R. J., James, V. M., Pepler, A., Steiner, I., Hörtnagel, K., et al. (2013) · Annals of Neurology · doi:10.1002/ana.24073 · Cited by 208
Dickey, A. S., & Strack, S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3159-11.2011 · Cited by 206
Inherited calcium channelopathies in the pathophysiology of arrhythmias
Venetucci, L. A., Denegri, M., Napolitano, C., & Priori, S. G. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.93 · Cited by 187
Bozon, B., Davis, S., & Laroche, S. (2002) · Hippocampus · doi:10.1002/hipo.10100 · Cited by 186
WAC, a Functional Partner of RNF20/40, Regulates Histone H2B Ubiquitination and Gene Transcription
Zhang, F., & Yu, X. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.024 · Cited by 177
Relationship between the structure of SET/TAF-Iβ/INHAT and its histone chaperone activity
Muto, S., Senda, M., Akai, Y., Sato, L., Suzuki, T., Nagai, R., Senda, T., & Horikoshi, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603762104 · Cited by 161
Ballif, B. C., Rosenfeld, J. A., Traylor, R. N., Theisen, A. P., Bader, P. I., Ladda, R. L., Sell, S. L., Steinraths, M., Surti, U., McGuire, M., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-1073-y · Cited by 150
Distinct functions of Egr gene family members in cognitive processes
Poirier, R. (2008) · Frontiers in Neuroscience · doi:10.3389/neuro.01.002.2008 · Cited by 125
Thierry, G., Bénéteau, C., Pichon, O., Flori, E., Isidor, B., Popelard, F., Delrue, M., Duboscq-Bidot, L., Thuresson, A., van Bon, B. W. M., et al. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35423 · Cited by 106
Loss of Cell Adhesion Causes Hydrocephalus in Nonmuscle Myosin II-B–ablated and Mutated Mice
Ma, X., Bao, J., & Adelstein, R. S. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0073 · Cited by 106
Filges, I., Shimojima, K. Y., Okamoto, N., Röthlisberger, B., Weber, P., Huber, A., Nishizawa, T., Datta, A., Miny, P., & Yamamoto, T. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2010.084582 · Cited by 103
Ma, X., Kawamoto, S., Hara, Y., & Adelstein, R. S. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0836 · Cited by 101
The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity
Munton, R. P., Vizi, S., & Mansuy, I. M. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.121 · Cited by 99
Takano, K., Liu, D., Tarpey, P. S., Gallant, E. M., Lam, A., Witham, S., Alexov, E., Chaubey, A., Stevenson, R. E., Schwartz, C. E., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds292 · Cited by 99
Minakuchi, M., Kakazu, N., Gorrín-Rivas, M. J., Abe, T., Copeland, T. D., Ueda, K., & Adachi, Y. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02000.x · Cited by 96
Asadollahi, R., Oneda, B., Sheth, F. J., Azzarello‐Burri, S., Baldinger, R., Joset, P., Latal, B., Knirsch, W., Desai, S., Baumer, A., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.17 · Cited by 83
Willemsen, M. H., Nijhof, B., Fencková, M., Nillesen, W. M., Bongers, E. M. H. F., Castells‐Nobau, A., Asztalos, L., Viràgh, E., van Bon, B. W. M., Tezel, E., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101490 · Cited by 68
Wentzel, C., Rajcan‐Separovic, E., Ruivenkamp, C. A. L., Chantot‐Bastaraud, S., Métay, C., Andrieux, J., Annerén, G., Gijsbers, A. C. J., Druart, L., Hyon, C., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.71 · Cited by 59
Further confirmation of the MED13L haploinsufficiency syndrome
van Haelst, M. M., Monroe, G. R., Duran, K. J., van Binsbergen, E., Breur, J. M. P. J., Giltay, J. C., & van Haaften, G. W. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.69 · Cited by 51
Cardiac Channel Molecular Autopsy for Sudden Unexpected Death in Epilepsy
Johnson, J. N., Tester, D. J., Bass, N. E., & Ackerman, M. J. (2010) · Journal of Child Neurology · doi:10.1177/0883073809343722 · Cited by 50
A human de novo mutation inMYH10phenocopies the loss of function mutation in mice
Tuzović, L., Yu, L., Zeng, W., Li, X., Lu, H. Y., Lu, H., Hagman, K. D. F., & Chung, W. K. (2013) · Rare Diseases · doi:10.4161/rdis.26144 · Cited by 49
Palumbo, O., Fichera, M., Palumbo, P., Rizzo, R., Mazzolla, E., Cocuzza, M. D., Carella, M., & Mattina, T. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36363 · Cited by 48
Extended spectrum of MBD5 mutations in neurodevelopmental disorders
Bonnet, C., Khan, A. A., Bresso, E., Vigouroux, C., Béri, M., Lejczak, S., Demeer, B., Andrieux, J., Philippe, C., Moncla, A., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.22 · Cited by 38
SET Nuclear Oncogene Associates with Microcephalin/MCPH1 and Regulates Chromosome Condensation
Leung, J. W. C., Leitch, A., Wood, J. L., Shaw-Smith, C. J., Metcalfe, K., Bicknell, L. S., Jackson, A. P., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208793 · Cited by 36
Hamdan, F. F., Daoud, H., Patry, L., Dionne‐Laporte, A., Spiegelman, D., Dobrzeniecka, S., Rouleau, G. A., & Michaud, J. L. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01890.x · Cited by 20
Self-citationLaPage, M. J., Russell, M. W. W., Bradley, D. J., & Dick, M. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.04.013 · Cited by 8
Flagged first, then by citations
Cited by
Sorted by citations
Gene expression elucidates functional impact of polygenic risk for schizophrenia
Fromer, M., Roussos, P., Sieberts, S. K., Johnson, J. S., Kavanagh, D. H., Perumal, T. M., Ruderfer, D. M., Oh, E. C., Topol, A., Shah, H. R., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4399 · Cited by 1,091
InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines
Li, Q., & Wang, K. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.004 · Cited by 1,057
Genetic studies in intellectual disability and related disorders
Vissers, L. E. L. M., Gilissen, C., & Veltman, J. A. (2016) · Nature Reviews Genetics · doi:10.1038/nrg3999 · Cited by 761
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Methyl-cpG-binding domain proteins: readers of the epigenome
Du, Q., Luu, P.-L., Stirzaker, C., & Clark, S. J. (2015) · Epigenomics · doi:10.2217/epi.15.39 · Cited by 544
Metadata
- Authors
- Hamdan, F. F., Srour, M., Capo-Chichi, J.-M., Daoud, H., Nassif, C., Patry, L., Massicotte, C., Ambalavanan, A., Spiegelman, D., Diallo, O., Henrion, E., Dionne-Laporte, A., Fougerat, A., Pshezhetsky, A. V., Venkateswaran, S., Rouleau, G. A., & Michaud, J. L.
- Affiliations
- CHU Sainte-Justine Research Center (CA)
- Montreal Children's Hospital (CA)
- Montreal Neurological Institute and Hospital (CA)
- Children's Hospital of Eastern Ontario (CA)
- Corresponding author
- Michaud, Jacques L.
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-10-30
- Volume
- 10
- Issue
- 10
- Pages
- e1004772
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC4214635
- OpenAlex
- W2058423880
- Cited by
- 419
- References
- 62
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 23 · 2023: 27 · 2022: 39 · 2021: 45 · 2020: 33 · 2019: 43 · 2018: 52 · 2017: 49 · 2016: 43 · 2015: 20
- FWCI
- 24.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- McGill University
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- de novo mutations, intellectual disability, exome sequencing, loss-of-function mutations, single nucleotide substitution, ARID1B, CHD2, FOXG1, GABRB3, NR2B subunit, MBD5, MED13L, SETBP1, Tbr1, TCF4, WDR45, protein network analysis, diagnostic yield, pathogenic variants
- MeSH terms
- Epilepsy, Humans, Intellectual Disability, RNA Splicing, Frameshift Mutation, Point Mutation, Sequence Deletion, Codon, Nonsense, Mutation, Missense, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review